G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|10|1115-1123

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.10, 2003-06, pp. : 1115-1123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents

By Chackalamannil Samuel   Xia Yan  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 493-505

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

By Janero David R   Lindsley Loren   Vemuri Venkata Kiran   Makriyannis Alexandros  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 995-1025

Informa Healthcare

Access to resources Recommend Favorite

Novel EP1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 435-438

Informa Healthcare

Access to resources Recommend Favorite

Thrombin Receptor Antagonists, Recent Advances in PAR-1 Antagonist Development

By  

Current Medicinal Chemistry, Vol. 9, Iss. 13, 2002-07 ,pp. : 1229-1250

Bentham Science Publishers

Access to resources Recommend Favorite